Double stranded RNA- relative to other TLR ligand-activated dendritic cells induce extremely polarized human Th1 responses

Cellular Immunology

Volumn 264, Issue 2, 2010, Pages 119-126

  Benwell, Risa K ^a   Hruska, Jennifer E ^a   Fritsche, Kevin L ^b   Lee, David R ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

CD4+ T cell differentiation; Dendritic cell; Human; Toll like receptor

Indexed keywords

DOUBLE STRANDED RNA; FLAGELLIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; LIGAND;

ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; MIXED LYMPHOCYTE CULTURE; PATHOLOGY; RNA VIRUS;

CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; FLAGELLIN; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-10; INTERLEUKIN-12; LIGANDS; LIPOPOLYSACCHARIDES; LYMPHOCYTE CULTURE TEST, MIXED; RNA VIRUSES; RNA, DOUBLE-STRANDED; TH1 CELLS; TH2 CELLS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 77955096531     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.05.008     Document Type: Article

References (45)

1. Mazzoni A., Segal D.M. Controlling the Toll road to dendritic cell polarization. J. Leukocyte Biol. 2004, 75:721-730.
2. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
3. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kB by Toll-like receptor 3. Nature 2001, 413:732-738.
4. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
5. Bauer S., Wagner H. Bacterial CpG-DNA licenses TLR9. Curr. Top. Microbiol. Immunol. 2002, 270:145-154.
6. Hochrein H., Schlatter B., O'Keeffe M., Wagner C., Schmitz F., Schiemann M., Bauer S., Suter M., Wagner H. Herpes simplex virus type-1 induces IFN-α production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl. Acad. Sci. USA 2004, 101:11416-11421.
7. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003, 3:984-993.
8. Didierlaurent A., Ferrero I., Otten L.A., Dubois B., Reinhardt M., Carlsen H., Blomhoff R., Akira S., Kraehenbuhl J.P., Sirard J.C. Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J. Immunol. 2004, 172:6922-6930.
9. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van Dyke T., Pulendran B. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 2003, 171:4984-4989.
10. Amsen D., Blander J.M., Lee G.R., Tanigaki K., Honjo T., Flavell R.A. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 2004, 117:515-526.
11. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 1999, 189:821-829.
12. de Jong E.C., Vieira P.L., Kalinski P., Schuitemaker J.H.N., Tanaka Y., Wierenga E.A., Yazdanbakhsh M., Kapsenberg M.L. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J. Immunol. 2002, 168:1704-1709.
13. Napolitani G., Rinaldi A., Bertoni F., Sallusto F., Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 2005, 6:769-776.
14. Roses R.E., Xu S., Xu M., Koldovsky U., Koski G., Czerniecki B.J. Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists. J. Immunol. 2008, 181:5120-5127.
15. Bender A., Sapp M., Schuler G., Steinman R.M., Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Meth. 1996, 196:121-135.
16. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P., Steinman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994, 180:83-93.
17. Benwell R.K., Lee D.R. Essential and synergistic roles of IL1 and IL6 in human Th17 differentiation directed by TLR ligand-activated dendritic cells. Clin. Immunol. 2010, 134:178-187.
18. Parish C.R. Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol. Cell Biol. 1999, 77:499-508.
19. Hsieh C.S., Heimberger A.B., Gold J.S., O'Garra A., Murphy K.M. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 1992, 89:6065-6069.
20. Hsieh C.S., Macatonia S.E., O'Garra A., Murphy K.M. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 1995, 181:713-721.
21. Bird J.J., Brown D.R., Mullen A.C., Moskowitz N.H., Mahowald M.A., Sider J.R., Gajewski T.F., Wang C.R., Reiner S.L. Helper T cell differentiation is controlled by the cell cycle. Immunity 1998, 9:229-237.
22. Asselin S., Conjeaud H., Minty A., Fradelizi D., Breban M. Stable polarization of peripheral blood T cells towards type 1 or type 2 phenotype after polyclonal activation. Eur. J. Immunol. 1998, 28:532-539.
23. Matsumoto M., Funami K., Tanabe M., Oshiumi H., Shingai M., Seto Y., Yamamoto A., Seya T. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 2003, 171:3154-3162.
24. Akira S., Takeda K. Toll-like receptor signaling. Nat. Rev. Immunol. 2004, 4:499-511.
25. Meylan E., Tschopp J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol. Cell 2006, 22:561-569.
26. Yoneyama M., Fujita T. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 2008, 29:178-181.
27. Kumar H., Koyama S., Ishii K.J., Kawai T., Akira S. Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J. Immunol. 2008, 180:683-687.
28. Van Duin D., Medzhitov R., Shaw A.C. Triggering TLR signaling in vaccination. Trends Immunol. 2006, 27:49-55.
29. Ashkar A.A., Yao X.D., Gill N., Sajic D., Patrick A.J., Rosenthal K.L. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 2004, 190:1841-1849.
30. Sharma S., Dominguez A.L., Hoelzinger D.B., Lustgarten J. CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged. Cancer Immunol., Immunotherapy 2008, 57:549-561.
31. Boivin N., Sergerie Y., Rivest S., Boivin G. Effect of pretreatment with Toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis. J. Infect. Dis. 2008, 198:664-672.
32. + T cell immunity together with a dendritic cell targeted vaccine. Proc. Natl. Acad. Sci. USA 2008, 105:2574-2579.
33. Zheng R., Cohen P.A., Paustian C.A., Johnson T.D., Lee W.T., Shu S., Koski G.K. Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12. Cancer Res. 2008, 68:4045-4049.
34. + Th1 immunity with poly IC as adjuvant. J. Exp. Med. 2009, 206:1589-1602.
35. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
36. Cruz A., Khader S.A., Torrado E., Fraga A., Pearl J.E., Pedrosa J., Cooper A.M., Castro A.G. Cutting edge: IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 2006, 177:1416-1420.
37. Hoeve M.A., Savage N.D.L., de Boer T., Langenberg D.M.L., de Waal Malefyt R., Ottenhoff T.H.M., Verreck F.A.W. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur. J. Immunol. 2006, 36:661-670.
38. Frleta D., Yu C.I., Klechevsky E., Flamar A.L., Zurawski G., Banchereau J., Palucka A.K. Influenza virus and poly(I:C) inhibit MHC class I-restricted presentation of cell-associated antigens derived from infected dead cells captured by human dendritic cells. J. Immunol. 2009, 182:2766-2776.
39. Kleinschek M.A., Muller U., Brodie S.J., Stenzel W., Kohler G., Blumenschein W.M., Straubinger R.K., McClanahan T., Kastelein R.A., Alber G. IL-23 Enhances the inflammatory cell response in Cryptococcus neoformans Infection and Induces a cytokine pattern distinct from IL-12. J. Immunol. 2006, 176:1098-1106.
40. Happel K.I., Dubin P.J., Zheng M., Ghilardi N., Lockhart C., Quinton L.J., Odden A.R., Shellito J.E. Divergent roles of Il-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 2005, 202:761-769.
41. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
42. Hunter C.A. New IL-12-family members: IL-23 and IL-27. Cytokines with divergent functions. Nat. Rev. Immunol. 2005, 5:521-531.
43. Ghilardi N., Kljavin N., Chen Q., Lucas S., Gurney A.L., De Sauvage F.J. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J. Immunol. 2004, 172:2827-2833.
44. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., Sedgwick J.D., Cua D.J. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003, 198:1951-1957.
45. Murphy K.M., Reiner S.L. The lineage decisions of helper T cells. Nat. Rev. 2002, 2:933-944.